文献速递眼底病与葡萄膜炎

非裔美国人眼病研究中的未矫正屈光不正

Uncorrected Refractive Error in the African American Eye Disease Study.
PubMed 文献 · JAMA Ophthalmol · 2024-01-01

该横断面研究纳入6337名40岁及以上自认非裔美国人,通过标准视力检查和验光评估未矫正屈光不正(UCRE)和未满足屈光需求(URN)。任何UCRE患病率为14.6%,任何URN患病率为5.4%;屈光矫正可改善超过三分之二视力损害者的视力。

要点

  • 在6337名非裔美国成人中,任何未矫正屈光不正的患病率为14.6%。
  • 任何未满足屈光需求的患病率为5.4%,其中URN1为157/2893,URN2为155/2891。
  • 屈光相关可矫正视力损害占视力损害参与者的68.7%。

核心结论

  • 作者认为,非裔美国成人中屈光不正相关可矫正视力损害负担高,是该人群视力损害的首位原因。
  • 作者建议提供视力保健和处方眼镜的全民覆盖,认为这是可负担且可实现的干预,可能将该人群视力损害负担降低超过三分之二,并可能提高生活质量和工作生产力。

研究设计与样本

  • 该研究为横断面研究,于2014年4月至2018年4月在加利福尼亚州英格尔伍德30个连续人口普查区纳入40岁及以上自认非裔美国人。
  • 参与者接受完整眼科检查及入户问卷,评估社会人口学、生活方式、生物学、医学、医疗保健和眼保健使用等危险因素。
  • 视力测量采用标准早期治疗糖尿病视网膜病变研究方案,进行非睫状肌麻痹自动验光并补充主觉验光。

主要发现

  • 在7957名符合条件的非裔美国人眼病研究(AFEDS)参与者中,6347人(80%)完成了入户访谈和临床检查。
  • 分析纳入6337名有完整屈光数据者,平均(标准差)年龄61(11)岁,女性3997人(63%)。
  • 有视力损害者中,屈光相关可矫正视力损害占68.7%。
  • 任何未矫正屈光不正总体患病率为14.6%(925/6337)。
  • 任何未满足屈光需求总体患病率为5.4%:URN1为157/2893,URN2为155/2891。

关键数值与推荐

  • 未矫正屈光不正定义为较好眼验光后视力提高2行或以上。
  • 未满足屈光需求定义为视力损害者较好眼验光后视力提高2行或以上。
  • URN1定义为较好眼呈现视力差于20/40但矫正后可达20/40或更好。
  • URN2定义为较好眼呈现视力差于20/40但屈光矫正后视力提高2行或以上。

临床怎么用

  • 原文结论建议提供视力保健和处方眼镜的全民覆盖,作者认为该干预可负担且可实现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Refractive error remains the largest cause of correctable visual impairment in the US. Correction of refractive error will reduce visual impairment and its associated morbidity but also improve quality of life and productivity. OBJECTIVE: To determine the burden of and risk factors (RFs) associated with any uncorrected refractive error (UCRE) and unmet refractive need (URN) in a population-based sample of African American adults. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study, conducted from April 2014 to April 2018, included a population-based sample of self-identified African American participants 40 years and older from 30 contiguous census tracts in Inglewood, California. Participants underwent a complete ophthalmic examination and an in-home-administered questionnaire to assess sociodemographic, lifestyle, biological, medical, and health care and eye care usage RFs associated with UCRE and URN. Measurements of visual acuity (VA) were performed using a standard Early Treatment Diabetic Retinopathy Study protocol. Noncycloplegic automated refraction with supplemental subjective refraction was performed. UCRE was defined as an improvement of 2 or more lines with refraction in the better-seeing eye. URN was defined as an improvement of 2 or more lines with refraction in the better-seeing eye in those persons who were visually impaired. Sex- and age-specific burden of UCRE and URN were calculated, and multiple regression analyses were used to identify independent RFs. Study data were analyzed from May 2018 to December 2023. EXPOSURES: Presence or absence of correctable refractive error. MAIN OUTCOMES AND MEASURES: Self-reported sex- and age-specific prevalence of and risk indicators of UCRE and URN. RESULTS: Of the 7957 eligible participants in the African American Eye Disease Study (AFEDS), 6347 (80%) completed both the in-home interview and the clinical examination. Of these, 6337 participants (mean [SD] age, 61 [11] years; 3997 female [63%]) with complete refractive error data were included in the analysis. Refractive error-related correctable visual impairment was present in over two-thirds of participants with visual impairment (68.7%). The overall prevalence of any UCRE was 14.6% (925 of 6337), and the overall prevalence of any URN was 5.4% (URN1 [those with presenting VA of worse than 20/40 in the better-seeing eye but who could achieve 20/40 or better with correction], 157 of 2893; URN2 [those with presenting VA of worse than 20/40 in the better-seeing eye but who could achieve an improvement of 2 or more lines with refractive correction], 155 of 2891). CONCLUSIONS AND RELEVANCE: Results of this cross-sectional study suggest a high burden of refractive error-associated correctable refractive error in African American adults, making it the leading cause of visual impairment in this population. Providing universal coverage for vision care and prescription glasses is an affordable and achievable health care intervention that could reduce the burden of visual impairment in African American adults by over two-thirds and likely raise the quality of life and work productivity, especially in this vulnerable minority population.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Dhablania N, Torres M, Burkemper B, et al. Uncorrected Refractive Error in the African American Eye Disease Study. JAMA Ophthalmol. 2024. PMID: 38386342. doi:10.1001/jamaophthalmol.2023.6781

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。